Sort by
Refine Your Search
-
Listed
-
Program
-
Field
-
The successful applicant must have a Ph.D. in Computer Science, Data Science, Statistics, Mathematics, Physics, Engineering or related field at the start of the appointment. Type Benefited Staff Special
-
strongrecord of scientific productivity is preferable. The successful applicant must have a Ph.D.in Computer Science, Data Science, Statistics, Mathematics, Physics, Engineering orrelated field at the start of
-
Full Time or Part Time? Full Time Shift Day Work Schedule Summary VP Area U of U Health - Academics Department 01337 - Molecular Medicine Program Location Campus City Salt Lake City, UT Type
-
inform public health, in particular, in low-income settings. Qualifications: PhD of equivalent in a relevant field including, but not limited to: evolutionary biology, epidemiology, biology, computational
-
on scientific problems, whether biomedical or other, and to applicants with a strong record of scientific productivity. The successful applicant must have a Ph.D. in Computer Science, Data Science, Statistics
-
translational science. Responsibilities 1. Coordinate and manage the progress and daily operations of our new NIH-funded clinical trial on sleep restriction and insulin sensitivity; monitor and report recruitment
-
expression, pregnancy, pregnancy-related conditions, genetic information, or protected veteran’s status. The University does not discriminate on the basis of sex in the education program or activity that it
-
Technology in Training, Education, and Consultation (U-TTEC) Lab (https://www.u-tteclab.com ) in the Department of Educational Psychology to provide direct mental health and behavioral services in
-
, prescriptions, basic vision coverage, and behavior health benefits. Employees are eligible for a discount of up to $40 per month on their premiums for participating in our Well-U Wellness Program. Our retirement
-
program for a position in the laboratory of Dr. Jens Lohr at Huntsman Cancer Institute. Our basic and translational research program aims to understand the evolution and treatment resistance of hematologic